Inicio › Leucemia linfoblástica aguda › Utah › Salt Lake City
Ensayos clínicos de Leucemia linfoblástica aguda en Salt Lake City, UT
10 estudios para Leucemia linfoblástica aguda buscan participantes en centros de Salt Lake City y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
ReclutandoFase 1
- Primary Children's Hospital, Salt Lake City
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
Reclutando
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies
ReclutandoFase 1
- Huntsman Cancer Institute, Salt Lake City
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
ReclutandoFase 1/2
- Primary Children's Hospital, Salt Lake City
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
ReclutandoFase 2
- Primary Children's Hospital, Salt Lake City
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
ReclutandoEstudio observacional
- University of Utah, Salt Lake City
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
ReclutandoFase 1/2
- University of Utah Huntsman Cancer Institute, Salt Lake City
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
ReclutandoFase 1
- University of Utah, Salt Lake City
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
ReclutandoFase 1/2
- Huntsman Cancer Institute, Salt Lake City
- Intermountain Healthcare, Salt Lake City
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
ReclutandoFase 1
- Primary Children's Hospital, Salt Lake City
Ensayos de Leucemia linfoblástica aguda en otras ciudades
- Houston, TX28 estudios
- New York City, NY23 estudios
- Seattle, WA21 estudios
- Baldwin Park, CA21 estudios
- Chicago, IL20 estudios
- Atlanta, GA19 estudios
- Memphis, TN16 estudios
- Washington, DC16 estudios
- Philadelphia, PA16 estudios
- Boston, MA15 estudios
- Los Angeles, CA14 estudios
- Mountain View, CA13 estudios
Otros estudios en Salt Lake City
- Cáncer de pulmón de células no pequeñas31 estudios
- Cáncer (todos los tipos)27 estudios
- Cáncer de seno27 estudios
- Cáncer del colon y del recto22 estudios
- Cáncer de pulmón21 estudios
- Melanoma21 estudios
- Mieloma múltiple21 estudios
- Cáncer metastásico20 estudios
- Cáncer de ovario19 estudios
- Obesidad18 estudios
- Leucemia mielógena aguda17 estudios
- Fallo cardíaco17 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.